| Tap a line for its trend | Last 12Mto Sep 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 38.36× | 38.36× | 36.87× | 37.25× | 29.21× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 0.75× | 0.88× | 0.52× | 0.84× | 0.89× | ||
| 0.43× | 0.43× | 0.40× | 0.39× | 0.39× | ||
| 0.86× | 0.86× | 0.85× | 0.70× | 0.73× | ||
| 0.73× | 0.73× | 0.82× | 0.72× | 0.69× |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/09/2026 | |
|---|---|---|---|---|---|---|
| Receivable Days (DSO) | 29.21 | 37.25 | 36.87 | 38.36 | 38.36 | |
| Working Capital Turnover | 0.89 | 0.84 | 0.52 | 0.88 | 0.75 | |
| Asset Turnover | 0.39 | 0.39 | 0.40 | 0.43 | 0.43 | |
| Cash Conversion (CFO/Net Income) | 0.73 | 0.70 | 0.85 | 0.86 | 0.86 | |
| CFO/EBITDA | 0.69 | 0.72 | 0.82 | 0.73 | 0.73 |